JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
WESTCHESTER, IL—James P. Zallie, President and CEO of Ingredion Inc . (NYSE:INGR), a $8.1 billion market cap company currently trading at an attractive P/E ratio of 12.7, recently sold 10,815 shares of the company’s common stock, according to a regulatory filing. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value estimates. The shares were sold at an average price of $125.876, resulting in a total transaction value of approximately $1.36 million.
The sale, executed on February 19, was carried out under a pre-established Rule 10b5-1 trading plan that Zallie adopted on November 6, 2024. Following this transaction, Zallie still holds 34,126 shares directly in the company. InvestingPro data shows the company maintains strong financial health with a "GREAT" overall score, supported by 28 consecutive years of dividend payments.
The reported sale price reflects a weighted average, with shares sold at prices ranging from $124.55 to $127.06. Zallie remains both a director and an officer at Ingredion, continuing to lead the company as its CEO. For deeper insights into INGR’s valuation and financial health, including 10+ additional ProTips and comprehensive analysis, visit InvestingPro.
In other recent news, Ingredion has reported fourth-quarter earnings per share (EPS) of $2.63, surpassing the consensus estimate of $2.56. However, the company’s revenue for the quarter was $1.8 billion, falling short of the expected $1.82 billion, which has raised concerns among investors. Ingredion has provided guidance for 2025, projecting EPS in the range of $10.75 to $11.55, aligning with consensus estimates but considered conservative. Analysts from BMO Capital Markets, Stephens, and Oppenheimer have adjusted their price targets for Ingredion to $133, $150, and $167, respectively, with each maintaining their current ratings. Despite the adjustments, analysts have noted the company’s strong fundamentals, including volume recovery and growth in high-margin specialty products.
Additionally, Ingredion announced the closure of its Vanscoy, Saskatchewan plant, which will result in a $66 million pre-tax charge. This strategic move is part of the company’s reassessment of its operations and asset value. The closure is expected to impact approximately 20 employees and is part of a broader effort to streamline operations. Analysts such as CFRA’s Arun Sundaram remain optimistic about Ingredion’s momentum, raising the 12-month target price to $174 and increasing the 2025 EPS estimate to $11.58. Investors will closely monitor Ingredion’s ability to navigate these developments and leverage its strategic initiatives for future growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.